BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37511358)

  • 21. G9a/EHMT2 is a Potential Prognostic Biomarker and Molecular Target in SHH Medulloblastoma.
    Souza BK; Freire NH; Jaeger M; de Farias CB; Brunetto AL; Brunetto AT; Roesler R
    Neuromolecular Med; 2022 Dec; 24(4):392-398. PubMed ID: 35113321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
    Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
    BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
    Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ
    Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paired box gene 8 (PAX8) expression is associated with sonic hedgehog (SHH)/wingless int (WNT) subtypes, desmoplastic histology and patient survival in human medulloblastomas.
    Harter PN; Baumgarten P; Zinke J; Schilling K; Baader S; Hartmetz AK; Schittenhelm J; Beschorner R; Liebner S; Schulte D; Plate KH; Gutwein P; Korshunov A; Pfister SM; Jones DT; Doberstein K; Mittelbronn M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):165-79. PubMed ID: 25287489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation.
    Tan IL; Wojcinski A; Rallapalli H; Lao Z; Sanghrajka RM; Stephen D; Volkova E; Korshunov A; Remke M; Taylor MD; Turnbull DH; Joyner AL
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3392-3397. PubMed ID: 29531057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional Networks.
    Po A; Abballe L; Sabato C; Gianno F; Chiacchiarini M; Catanzaro G; De Smaele E; Giangaspero F; Ferretti E; Miele E; Besharat ZM
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained hedgehog signaling in medulloblastoma tumoroids is attributed to stromal astrocytes and astrocyte-derived extracellular matrix.
    Cheng Y; Franco-Barraza J; Wang Y; Zheng C; Zhang L; Qu Y; Long Y; Cukierman E; Yang ZJ
    Lab Invest; 2020 Sep; 100(9):1208-1222. PubMed ID: 32457352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sox2 requirement in sonic hedgehog-associated medulloblastoma.
    Ahlfeld J; Favaro R; Pagella P; Kretzschmar HA; Nicolis S; Schüller U
    Cancer Res; 2013 Jun; 73(12):3796-807. PubMed ID: 23596255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis.
    Zhou H; Wang YX; Wu M; Lan X; Xiang D; Cai R; Ma Q; Miao J; Fang X; Wang J; Luo D; He Z; Cui Y; Liang P; Wang Y; Bian XW
    J Pathol; 2024 Apr; 262(4):427-440. PubMed ID: 38229567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.
    Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM
    Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipidome signatures of metastasis in a transgenic mouse model of sonic hedgehog medulloblastoma.
    Huang D; Liu J; Eldridge RC; Gaul DA; Paine MRL; Uppal K; MacDonald TJ; Fernández FM
    Anal Bioanal Chem; 2020 Oct; 412(25):7017-7027. PubMed ID: 32794007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup.
    da Silva LS; Mançano BM; de Paula FE; Dos Reis MB; de Almeida GC; Matsushita M; Junior CA; Evangelista AF; Saggioro F; Serafini LN; Stavale JN; Malheiros SMF; Lima M; Hajj GNM; de Lima MA; Taylor MD; Leal LF; Reis RM
    J Mol Diagn; 2020 Jul; 22(7):957-966. PubMed ID: 32380172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time.
    Shuangshoti S; Tadadontip P; Techavichit P; Thorner PS; Shuangshoti S; Teerapakpinyo C
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):538-543. PubMed ID: 31343993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicator.
    Korshunov A; Okonechnikov K; Stichel D; Ryzhova M; Schrimpf D; Sahm F; Sievers P; Absalyamova O; Zheludkova O; Golanov A; Jones DTW; Pfister SM; von Deimling A; Kool M
    Neuro Oncol; 2021 Sep; 23(9):1576-1585. PubMed ID: 33589929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropilin-2 contributes to tumorigenicity in a mouse model of Hedgehog pathway medulloblastoma.
    Hayden Gephart MG; Su YS; Bandara S; Tsai FC; Hong J; Conley N; Rayburn H; Milenkovic L; Meyer T; Scott MP
    J Neurooncol; 2013 Nov; 115(2):161-8. PubMed ID: 24026530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma.
    Doucette TA; Yang Y; Pedone C; Kim JY; Dubuc A; Northcott PD; Taylor MD; Fults DW; Rao G
    Neurosurgery; 2012 Apr; 70(4):1003-10; discussion 1010. PubMed ID: 22037313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis.
    Li Y; Song Q; Day BW
    Acta Neuropathol Commun; 2019 Jul; 7(1):123. PubMed ID: 31362788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Expression of Mitochondrial Biogenesis Markers in Mouse and Human SHH-Subtype Medulloblastoma.
    Łastowska M; Karkucińska-Więckowska A; Waschek JA; Niewiadomski P
    Cells; 2019 Mar; 8(3):. PubMed ID: 30841515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
    Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
    PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation.
    Adolphe C; Millar A; Kojic M; Barkauskas DS; Sundström A; Swartling FJ; Hediyeh-Zadeh S; Tan CW; Davis MJ; Genovesi LA; Wainwright BJ
    Mol Cancer Res; 2021 Nov; 19(11):1831-1839. PubMed ID: 34330843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.